5.105USD-0.87%Mkt Cap: 1.04B USDP/E: —Last update: 2026-06-01
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulati…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.04B USD
Enterprise Value1.14B USD
Revenue (TTM)—
Gross Profit-81.40M USD
Net Income (TTM)-118.84M USD
Revenue/Share—
Last Price5.105 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees70
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS8051111016
Valuation
P/E (Trailing)—
P/E (Forward)-14.34
PEG—
EV/EBITDA-8.59
EV/Revenue—
P/S—
P/B6.48
EPS (TTM)-0.56
EPS (Forward)-0.36
52W Range
1.98062% of range7.005
52W High7.005 USD
52W Low1.980 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-58.50%
ROA-46.89%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-101.04M USD
CapEx (TTM)22.00K USD
FCF Margin—
FCF Yield-5.53%
Net Debt-174.03M USD
Net Debt/EBITDA1.31
Balance Sheet
Debt/Equity0.15
Current Ratio13.47
Quick Ratio13.21
Book Value/Sh0.8020 USD
Cash/Share0.8050 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateApr 28, 2017
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)10.81 USD
Target Range9.000 USD – 16.00 USD
# Analysts8
Ownership
Shares Out.204.93M
Float130.12M
Insiders2.63%
Institutions104.25%
Short Interest
Short Ratio22.3d
Short % Float15.92%
Short % Out.13.62%
Shares Short27.91M
Short (prev mo.)27.67M
Technical
SMA 505.292 (-3.5%)
SMA 2004.934 (+3.5%)
Beta0.28
S&P 52W Chg27.70%
Avg Vol (30d)1.15M
Avg Vol (10d)1.51M
Technical Indicators
RSI (14)49.2
MACD-0.0448
MACD Signal-0.0759
MACD Hist.+0.0311
BB Upper5.426 USD
BB Middle5.133 USD
BB Lower4.839 USD
BB Width11.44%
ATR (14)0.2663 USD
Vol Ratio (20d)0.64x